Largest Decentralized Study of its Kind Shows High Levels of Engagement with Huma’s Study App
Source: Huma Therapeutics Ltd Copyright: The Authors URL: https://www.jmir.org/2023/1/e4060 License: Creative Commons Attribution (CC-BY) More than 90% of 2524 participants invited to join a fully remote COVID-19 study, conducted by Cambridge researchers, downloaded and registered on the study app [1]. Approximately 75% of participants completed digital biomarker assessments such as resting heart rate, temperature, and oxygen saturation at least once per week [1]. Participants were aged 45-70 years and took part for an average of 8 months [1]. LONDON, January 13, 2023. Today, Huma Therapeutics Limited (“Huma”), a leading global digital health company, announced the results of a new study in collaboration with the MedicalRead More →